401 related articles for article (PubMed ID: 23725303)
1. Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV).
Tirado-Sánchez A; Espíndola YS; Ponce-Olivera RM; Bonifaz A
J Cosmet Dermatol; 2013 Jun; 12(2):103-7. PubMed ID: 23725303
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
Thiboutot D; Gold MH; Jarratt MT; Kang S; Kaplan DL; Millikan L; Wolfe J; Loesche C; Baker M
Cutis; 2001 Oct; 68(4 Suppl):10-9. PubMed ID: 11845943
[TBL] [Abstract][Full Text] [Related]
3. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris.
Cunliffe WJ; Danby FW; Dunlap F; Gold MH; Gratton D; Greenspan A
Eur J Dermatol; 2002; 12(4):350-4. PubMed ID: 12095880
[TBL] [Abstract][Full Text] [Related]
4. Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
Egan N; Loesche MC; Baker MM
Cutis; 2001 Oct; 68(4 Suppl):20-4. PubMed ID: 11845944
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
Goreshi R; Samrao A; Ehst BD
J Drugs Dermatol; 2012 Dec; 11(12):1422-6. PubMed ID: 23377511
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial.
Shalita A; Weiss JS; Chalker DK; Ellis CN; Greenspan A; Katz HI; Kantor I; Millikan LE; Swinehart T; Swinyer L; Whitmore C; Baker M; Czernielewski J
J Am Acad Dermatol; 1996 Mar; 34(3):482-5. PubMed ID: 8609263
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study of the efficacy and tolerability of 0.1 and 0.03 p.100 adapalene gel and 0.025 p.100 tretinoin gel in the treatment of acne].
Alirezai M; Meynadier J; Jablonska S; Czernielewski J; Verschoore M
Ann Dermatol Venereol; 1996; 123(3):165-70. PubMed ID: 8761775
[TBL] [Abstract][Full Text] [Related]
8. The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Sep; 12(9):1033-8. PubMed ID: 24002152
[TBL] [Abstract][Full Text] [Related]
9. Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris.
Kakita L
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S51-4. PubMed ID: 10898831
[TBL] [Abstract][Full Text] [Related]
10. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial.
Ioannides D; Rigopoulos D; Katsambas A
Br J Dermatol; 2002 Sep; 147(3):523-7. PubMed ID: 12207595
[TBL] [Abstract][Full Text] [Related]
11. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
Thiboutot D; Arsonnaud S; Soto P
J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s3-10. PubMed ID: 18575220
[TBL] [Abstract][Full Text] [Related]
13. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris.
Nyirady J; Grossman RM; Nighland M; Berger RS; Jorizzo JL; Kim YH; Martin AG; Pandya AG; Schulz KK; Strauss JS
J Dermatolog Treat; 2001 Sep; 12(3):149-57. PubMed ID: 12243706
[TBL] [Abstract][Full Text] [Related]
14. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Jul; 12(7):790-4. PubMed ID: 23884492
[TBL] [Abstract][Full Text] [Related]
15. Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study.
Fleischer AB; Shalita A; Eichenfield LF; Abramovits W; Lucky A; Garrett S;
J Drugs Dermatol; 2010 Jan; 9(1):33-40. PubMed ID: 20120423
[TBL] [Abstract][Full Text] [Related]
16. Is switching retinoids a sound strategy for the treatment of acne vulgaris?
Gold LS; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s11-7. PubMed ID: 18575221
[TBL] [Abstract][Full Text] [Related]
17. A comparison of adapalene gel 0.1% vs. tretinoin gel 0.025% in the treatment of acne vulgaris in China.
Tu P; Li GQ; Zhu XJ; Zheng J; Wong WZ
J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():31-6. PubMed ID: 11843231
[TBL] [Abstract][Full Text] [Related]
18. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
Gollnick HP; Draelos Z; Glenn MJ; Rosoph LA; Kaszuba A; Cornelison R; Gore B; Liu Y; Graeber M;
Br J Dermatol; 2009 Nov; 161(5):1180-9. PubMed ID: 19466959
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial.
Prasad S; Mukhopadhyay A; Kubavat A; Kelkar A; Modi A; Swarnkar B; Bajaj B; Vedamurthy M; Sheikh S; Mittal R
Indian J Dermatol Venereol Leprol; 2012; 78(4):459-67. PubMed ID: 22772617
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.
Tanghetti E; Dhawan S; Green L; Del Rosso J; Draelos Z; Leyden J; Shalita A; Glaser DA; Grimes P; Webster G; Barnett P; Le Gall N
J Drugs Dermatol; 2010 May; 9(5):549-58. PubMed ID: 20480800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]